These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19492145)

  • 21. The year in interventional cardiology.
    Dixon SR; Grines CL; O'Neill WW
    J Am Coll Cardiol; 2010 May; 55(20):2272-86. PubMed ID: 20466207
    [No Abstract]   [Full Text] [Related]  

  • 22. Weighing benefits and risks--the FDA's review of prasugrel.
    Unger EF
    N Engl J Med; 2009 Sep; 361(10):942-5. PubMed ID: 19726770
    [No Abstract]   [Full Text] [Related]  

  • 23. [Letter to Kardiologia Polska concerning optimal treatment of myocardial infarction].
    Grajek S
    Kardiol Pol; 2012; 70(2):213-4. PubMed ID: 22427099
    [No Abstract]   [Full Text] [Related]  

  • 24. A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38.
    Wiviott SD; Braunwald E; Murphy SA; Antman EM;
    Am J Cardiol; 2008 May; 101(9):1367-70. PubMed ID: 18435974
    [No Abstract]   [Full Text] [Related]  

  • 25. Prasugrel in clinical practice.
    Bhatt DL
    N Engl J Med; 2009 Sep; 361(10):940-2. PubMed ID: 19605807
    [No Abstract]   [Full Text] [Related]  

  • 26. Prasugrel (Effient) vs. clopidogrel (Plavix).
    Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.
    Capranzano P; Ferreiro JL; Angiolillo DJ
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):361-9. PubMed ID: 19379060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prasugrel: Clinical development and therapeutic application.
    Guerra DR; Tcheng JE
    Adv Ther; 2009 Nov; 26(11):999-1011. PubMed ID: 20020231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The FDA prasugrel review: adjudication of myocardial infarction controversy.
    Serebruany VL
    Cardiology; 2009; 114(2):126-9. PubMed ID: 19506374
    [No Abstract]   [Full Text] [Related]  

  • 30. [Optimal antiplatelet and antithrombotic therapy in patients with ST elevation myocardial infarction].
    Koziński M; Grześk G; Kubica J
    Kardiol Pol; 2012; 70(2):206-12. PubMed ID: 22427098
    [No Abstract]   [Full Text] [Related]  

  • 31. Prasugrel development - claims and achievements.
    Serebruany V; Shalito I; Kopyleva O
    Thromb Haemost; 2009 Jan; 101(1):14-22. PubMed ID: 19132184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.
    Mousa SA; Jeske WP; Fareed J
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):170-6. PubMed ID: 20299391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischaemia versus bleeding: the art of clinical decision-making.
    Stone GW
    Lancet; 2009 Feb; 373(9665):695-6. PubMed ID: 19249613
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interview with Prof. Franz-Joseph Krozingen: Interventional cardiology on the success course].
    Neumann FJ
    MMW Fortschr Med; 2010 Apr; 152(13):18. PubMed ID: 20443337
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiplatelet agents--problem for cardiac surgeon].
    Bochenek A; Wilczyński M
    Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictors of myocardial infarction after an acute coronary syndrome with clopidogrel and prasugrel.
    Lalor N; Conde D; Rodriguez L; Elissamburu P; Trivi M
    Am J Emerg Med; 2013 Aug; 31(8):1287-8. PubMed ID: 23806726
    [No Abstract]   [Full Text] [Related]  

  • 37. Is prasugrel more effective than clopidogrel in patients with acute coronary syndrome scheduled for PCI?
    Graber MA; Dachs R; Darby-Stewart A
    Am Fam Physician; 2008 Dec; 78(11):1252-3. PubMed ID: 19069017
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of antiplatelet therapy in the secondary prevention of coronary artery disease.
    Behan MW; Chew DP; Aylward PE
    Curr Opin Cardiol; 2010 Jul; 25(4):321-8. PubMed ID: 20386440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversies in acute cardiovascular care.
    Taylor J
    Eur Heart J; 2014 Mar; 35(9):535. PubMed ID: 24730030
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
    Jackson G
    Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.